4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017770
Chief Financial Officer sold 1,461 shares at $16.74 ($24,457)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2021-03-02 | Sale | −1,461 | $16.74 | $24,457 | 174,343 | D |
| Open-market sales · 1,461 sh · avg $16.74 · $24,457 | |||||||
Loading xslF345X03/doc4.xml…